RJA
ANGO icon

Raymond James & Associates’s AngioDynamics ANGO Stock Holding History

Raymond James & Associates’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,111
Closed -$210K – 3799
2023
Q2 		$210K Buy
20,111
+691
+4% +$6.65K ﹤0.01% 3461
2023
Q1 		$201K Buy
19,420
+2,581
+15% +$33K ﹤0.01% 3494
2022
Q4 		$232K Sell
16,839
-37,979
-69% -$528K ﹤0.01% 3366
2022
Q3 		$1.12M Buy
54,818
+10,449
+24% +$229K ﹤0.01% 2325
2022
Q2 		$859K Sell
44,369
-316
-0.7% -$6.47K ﹤0.01% 2540
2022
Q1 		$963K Sell
44,685
-49,322
-52% -$1.12M ﹤0.01% 2621
2021
Q4 		$2.59M Buy
94,007
+35,068
+59% +$968K ﹤0.01% 1988
2021
Q3 		$1.53M Sell
58,939
-11,310
-16% -$302K ﹤0.01% 2287
2021
Q2 		$1.91M Buy
70,249
+4,690
+7% +$115K ﹤0.01% 2133
2021
Q1 		$1.53M Sell
65,559
-6,682
-9% -$135K ﹤0.01% 2202
2020
Q4 		$1.11M Buy
72,241
+33,272
+85% +$422K ﹤0.01% 2274
2020
Q3 		$470K Buy
+38,969
New +$370K ﹤0.01% 2676

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's ANGO Position: Q3 2023 in Review

Raymond James & Associates sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 20,111 shares — an estimated $210K sold.

Raymond James & Associates first reported a position in ANGO in Q3 2020 and held it in 12 quarters. The position peaked at $2.59M in Q4 2021. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

  • Raymond James & Associates reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
  • Raymond James & Associates sold 20,111 AngioDynamics shares in Q3 2023, an estimated $210K.
  • Raymond James & Associates first reported a position in AngioDynamics in Q3 2020 and held it in 12 quarters.
  • Raymond James & Associates's AngioDynamics position peaked at $2.59M in Q4 2021.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.